Clinical study of Darvyadi Kwatha in Hyperlipidemia of Sthula Subjects

A RANDOMIZED CONTROLLED CLINICAL STUDY OF DARVYADI KWATHA IN HYPERLIPIDEMIA OF STHULA SUBJECTS - RCDH

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027145

Enrollment

Registered

2020-08-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: DARVYADI KWATHA 80ml early morning empty stomach given orally for 30 days: DARVYADI KWATHA 80 ml early morning empty stomach given orally for 30 days Control Intervention1: Yavamalak ch

Eligibility

Inclusion criteria

Inclusion criteria: BMI >25 AND UP TO 34.9 WITH Serum total cholesterol 200 mg/dl to 240 mg/dl OR Serum triglyceride 150 mg/dl to 300mg/dl

Exclusion criteria

Exclusion criteria: Subjects having history of any critical illness. Patients already taking medicine for Hyperlipidemia. Subjects not willing for trial. Dyslipidemia due to consumption of drugs such as Glucocorticoids. Patients with DM, HTN, Endocrine disorders, cardiac and renal impairment.Pregnant females and lactating mothers.

Design outcomes

Primary

Measure	Time frame
REDUCTION IN SERUM CHOLESTEROL AND REDUCTION IN SERUM TRIGLYCERIDESTimepoint: IN 40 DAYS	—

Secondary

Measure	Time frame
REDUCTION IN BMI AND STHAULYA LAKSHANATimepoint: IN 40 DAYS	—

Countries

India

Contacts

Public ContactRohini Ashok Kathale

GOVERNMENT AYURVED COLLEGE VAZIRABAD, NANDED

drsharmili24@gmail.com9325565009

Outcome results